Business & Finance
BioPharmX's net loss widens to USD4.4m in Q3 2019
7 December 2018 -

Pharmaceutical company BioPharmX Corporation (NYSE American:BPMX) stated on Thursday its net loss of USD4.4m (USD0.02 per share) for the quarter ended 31 October 2018.

This marks a drop in earnings when compared with a lower net loss of USD3.7m (USD0.05 per share) during the prior fiscal year's third quarter.

Revenues of USD10,000 were generated for the third quarter ended 31 October 2018,down over revenues of USD18,000 in the prior fiscal year's third quarter.

Total operating expenses were USD4.4m for the third quarter ended 31 October 2018, a rise versus total operating expenses of USD3.7m in the prior fiscal year's third quarter.

As of 31 October 2018, the cash and cash equivalents were USD3.0m.

Login
Username:

Password: